LAUREN SCHAAF: Open Payments
NPI 1023891363 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 44 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $893 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $248 |
| ABBVIE INC. | 14 | $215 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Lilly USA, LLC | 3 | $69 |
| PFIZER INC. | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Ozempic, QULIPTA, VRAYLAR, MOUNJARO, AIRSUPRA, Rybelsus, Wegovy, BREZTRI.
Industry payments across VA — which companies pay providers there.
